ADAG three-lens brief
Evidence-based stock research on ADAG. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +3.90% yesterday. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Moved +3.90% yesterday.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 33.1pp over 30 days.
- Negative free cash flow last quarterly (-$12.16M).
- Earnings scheduled 2026-12-02.
ADAG closed at $2.13 (+3.90%) as of 2026-11-12. Market cap: $143.02M. Price is below the 50-day MA and below the 200-day MA. Positives: moved +3.90% yesterday.. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; underperforming SPY by 33.1pp over 30 days.. Last quarter: Revenue $9.29M, free cash flow -$12.16M. Watching for: 2026-12-02 earnings release (20 days out).
Why three lenses on ADAG, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ADAG across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ADAG" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ADAG brief"></iframe>